In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 6, 1999, Pages 827-829

  Hossain, Mohammad Ashraf ^a   Maesaki, Shigefumi ^a   Mitsutake, Kotaro ^a   Kakeya, Hiroshi ^a   Sasaki, Eisuke ^a   Tomono, Kazunori ^a   Tashiro, Takayoshi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; POSACONAZOLE; TRIAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG RESPONSE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN;

EID: 0032763621     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.6.827     Document Type: Article

References (7)

1. Johnson, E. M., Warnock, D. W., Luker, J., Porter, S. R. & Scully, C. (1995). Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Journal of Antimicrobial Chemotherapy 35, 103-14.
2. Lamb, D. C., Corran, A., Baldwin, B. C., Kwon-Chung, J. & Kelly, S. L. (1995). Resistant P45091A1 activity in azole antifungal tolerant. Cryptococcus neoformans from AIDS patients. FEBS Letters 368, 326-30.
3. Galgiani, J. N. & Lewis, M. L. (1997). In-vitro studies of activities of the antifungal triazole SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrobial Agents and Chemotherapy 41, 180-3.
4. Law, D., Moore, C. B. & Denning, D. W. (1997). Activity of SCH56592 compared with those of fluconazole and itraconazole against Candida spp. Antimicrobial Agents and Chemotherapy 41, 2310-1.
5. Tanaka, K., Miyazaki, T., Maesaki, S., Mitsutake, K., Kakeya, H., Yamamoto, Y. et al. (1996). Detection of Cryptococcus neoformans gene in patients with pulmonary cryptococcosis. Journal of Clinical Microbiology 34, 2826-8.
6. The Guidelines of the Laboratory Animal Center for Biomedical Research, Nagasaki University School of Medicine. (1995).
7. Hossain, M. A., Maesaki, S., Kakeya, H., Noda, T., Yanagihara, K., Sasaki, E. et al. (1998). Efficacy of NS-718, a novel lipid nanosphere-encapsulated amphotericin B, against Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy 42, 1722-5.